Identification of a homozygous deletion at 8p12-21 in a human prostate cancer xenograft

被引:0
|
作者
Van Alewijk, DC
Van Der Weiden, MM
Eussen, BJ
Van Den Andel-Thijssen, LD
Ehren-Van Eekelen, CC
König, JJ
Van Steenbrugge, GJ
Dinjens, WN
Trapman, J
机构
[1] Erasmus Univ, Dept Pathol, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands
[3] Erasmus Univ, Dept Urol, NL-3000 DR Rotterdam, Netherlands
来源
GENES CHROMOSOMES & CANCER | 1999年 / 24卷 / 02期
关键词
D O I
10.1002/(SICI)1098-2264(199902)24:2<119::AID-GCC4>3.0.CO;2-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
One of the most frequent genetic abnormalities in prostate cancer is loss of the complete or part of the short arm of chromosome 8, indicating the localization of one or more tumor suppressor genes on this chromosomal arm. Using allelotyping, a frequently deleted region in prostate cancer in a genetic interval of approximately 17 cM between sequence tagged sites D8S87 and D8S133 at chromosome arm 8p12-21 was previously detected. A detailed physical map of this region is now available. Using known and novel polymorphic and nonpolymorphic sequence tagged sites in this interval, a search for homozygous deletions in DNAs from 14 prostate cancer-derived cell lines and xenografts was carried out. In DNA from xenograft PC133, the presence of a small homozygously deleted region of 730-1,320 kb was unambiguously established. At one site, the deletion disrupts the Werner syndrome gene. Data from allelotyping were confirmed and extended by fluorescence in situ hybridization analysis of PC133 chromosome spreads using centromere, YAC, and PAC chromosome 8 probes. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 50 条
  • [21] High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22
    Arbieva, ZH
    Banerjee, K
    Kim, SY
    Edassery, SL
    Maniatis, VS
    Horrigan, SK
    Westbrook, CA
    GENOME RESEARCH, 2000, 10 (02) : 244 - 257
  • [22] Frequent allelic loss and homozygous deletion in chromosome band 8p23 in oral cancer
    Ishwad, CS
    Shuster, M
    Bockmühl, U
    Thakker, N
    Shah, P
    Toomes, C
    Dixon, M
    Ferrell, RE
    Gollin, SM
    INTERNATIONAL JOURNAL OF CANCER, 1999, 80 (01) : 25 - 31
  • [23] Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas
    Chiosea, Simion
    Krasinskas, Alyssa
    Cagle, Philip T.
    Mitchell, Kisha A.
    Zander, Dani S.
    Dacic, Sanja
    MODERN PATHOLOGY, 2008, 21 (06) : 742 - 747
  • [24] Functional evidence for a metastasis suppressor gene for rat prostate cancer within a 60-kilobase region on human chromosome 8p21-p12
    Nihei, N
    Kouprina, N
    Larionov, V
    Oshima, J
    Martin, GM
    Ichikawa, T
    Barrett, JC
    CANCER RESEARCH, 2002, 62 (02) : 367 - 370
  • [25] Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer
    Kluth, Martina
    Ahrary, Ramin
    Hube-Magg, Claudia
    Ahmed, Malik
    Volta, Heinke
    Schwemin, Catina
    Steurer, Stefan
    Wittmer, Corinna
    Wilczak, Waldemar
    Krech, Eike Burandt Till
    Adam, Meike
    Michl, Uwe
    Heinzer, Hans
    Salomon, Georg
    Graefen, Markus
    Koop, Christina
    Minner, Sarah
    Simon, Ronald
    Sauter, Guido
    Schlomm, Thorsten
    ONCOTARGET, 2015, 6 (29) : 27966 - 27979
  • [26] GENOMIC DELETION OF CHROMOSOME 12P IS AN INDEPENDENT PROGNOSTIC MARKER IN PROSTATE CANCER
    Pompe, Raisa
    Kluth, Martina
    Minner, Sarah
    Gild, Philipp
    Simon, Ronald
    Tennstedt, Pierre
    Graefen, Markus
    Sauter, Guido
    Schlomm, Thorsten
    JOURNAL OF UROLOGY, 2015, 193 (04): : E675 - E676
  • [27] Mapping of a deletion interval on 8p21-22 in prostate cancer by gene dosage PCR validated by tissue micro array
    Schmidt, H.
    Semjonow, A.
    Csiszar, K.
    Korsching, E.
    Brandt, B.
    Eltze, E.
    PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (05) : 278 - 278
  • [28] Identification of a large homozygous SPG21 deletion in a Chinese patient with Mast syndrome
    Xue, Yan-Yan
    Huang, Xue-Rong
    Dong, Hai-Lin
    Wu, Zhi-Ying
    Li, Hong-Fu
    CNS NEUROSCIENCE & THERAPEUTICS, 2021, 27 (10) : 1251 - 1253
  • [29] Workgroup 2: Human xenograft models of prostate cancer
    Stearns, ME
    Ware, JL
    Agus, DB
    Chang, CJ
    Fidler, IJ
    Fife, RS
    Goode, R
    Holmes, E
    Kinch, MS
    Peehl, DM
    Pretlow, TG
    Thalmann, GN
    PROSTATE, 1998, 36 (01): : 56 - 58
  • [30] Molecular characterization of a 7p15-21 homozygous deletion in a Wilms tumor
    Sossey-Alaoui, K
    Vieira, L
    David, D
    Boavida, MG
    Cowell, JK
    GENES CHROMOSOMES & CANCER, 2003, 36 (01): : 1 - 6